CytoDyn reached enrollment of 195 patients in its phase 3 trial for COVID-19 patients with severe-to-critical symptoms
On Aug. 25, 2020, CytoDyn announced the Company had reached the requisite number of enrolled patients in its…
-
-
Man in Hong Kong was the first confirmed case of Coronavirus reinfection
On Aug. 24, 2020, Hong Kong University researchers reported that a 33-year-old man in Hong Kong had been…
-
NantKwest and ImmunityBio inked an agreement for joint development, manufacturing, marketing, and commercialization of COVID-19 vaccine
On Aug. 24 2020, NantKwest and ImmunityBio announced an agreement to jointly develop, manufacture, market, and commercialize therapeutics…
-
Largest global study on hydroxychloroquine safety finds increased cardiovascular risk with azithromycin
On Aug. 24, 2020, the combination of hydroxychloroquine and azithromycin has been linked to significant cardiovascular risks, including…
-
University of Oxford study described which cancer patients are more vulnerable to COVID-19
On Aug. 24, 2020, a published study led by the Universities of Oxford and Birmingham found that, compared…
-
COVID-19 drug candidate Brilacidin achieved a selectivity index among the highest reported
On Aug. 24, 2020, Innovation Pharma reported receiving additional data from a U.S. Regional Biocontainment Laboratory (RBL) based…
-
Genomic analysis revealed many animal species may be vulnerable to SARS-CoV-2 infection
On Aug. 24, 2020, humans are not the only species facing a potential threat from SARS-CoV-2, the novel…
-
Novavax initiated phase 2 portion of phase 1/2 clinical trial of COVID-19 vaccine
On Aug. 24, 2020, Novavax announced that the first volunteers were enrolled in the Phase 2 portion of…
-
Biotechnology | COVID-19 | FDA | Therapeutics
XBiotech announced COVID-19 candidate therapy
On Aug. 24, 2020, XBiotech announced that the U.S. Food and Drug Administration (FDA) issued an emergency use…
-
Trevena announced initiation of TRV027 study in COVID-19 patients in collaboration with Imperial College London
On Aug. 24, 2020,Trevena announced that Imperial College London (ICL) had initiated a proof-of-concept study for TRV027 in…
-
AXIM Biotechnologies signed exclusive licensing, manufacturing and distribution agreement for production of COVID-19 rapid neutralizing antibody test
On Aug. 24, 2020, AXIM Biotechnologies announced that it had signed an exclusive limited licensing, manufacturing and distribution…
-
Catalent signed agreement with AstraZeneca to expand manufacturing support for COVID-19 vaccine AZD1222
On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…
-
Quest Diagnostics Foundation launched initiative to reduce health disparities in underserved communities
On Aug. 24, 2020, the Quest Diagnostics Foundation announced a wide-ranging initiative to address and reduce health disparities…
-
FDA issued Emergency Use Authorization for convalescent plasma as potential promising COVIDﾖ19 treatment
On Aug. 23, 2020, the FDA issued an emergency use authorization (EUA) for investigational convalescent plasma for the…
-
Mayo Clinic discontinued enrollment in Expanded Access Program for convalescent plasma with FDA Emergency Use Authorization
On Aug. 23, 2020, the Mayo Clinic announced that with the FDA Emergency Use Authorization of convalescent plasma,…
-
172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility
On Aug. 23, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…
-
Failure to ﾑflatten the curveﾒ may kill more people than we thought
On Aug. 21, 2020, research by the University of Minnesota and the University of Washington found that every…
-
CDC published ACIP 2020-21 influenza vaccination recommendations
On Aug. 21, 2020, the CDC published Immunization Practices Advisory Committee (ACIP) 2020-21 influenza vaccination recommendations. Routine annual…
-
JAMA reported on effect of remdesivir vs standard care on clinical status in patients with moderate COVID-19
On Aug. 21, 2020, JAMA reported that hospitalized patients with moderate COVID-19 randomized to a 5-day course of…
-
Oragenics signed a process development and manufacturing agreement with Avid Bioservices for Coronavirus vaccine
On Aug. 20, 2020, Oragenics and Avid Bioservices announced a process development and drug substance manufacturing agreement. Avid…
-
Sorrento announced agreement to acquire SmartPharm and develop gene-encoded therapeutic antibodies for COVID-19 and cancer therapeutics
On Aug. 20, 2020, Sorrento Therapeutics and SmartPharm Therapeutics announced the signing of a merger agreement under which…
-
GT Biopharma updated development of TriKE(TM) therapeutic for treatment of COVID-19 infection
On Aug. 20, 2020, GT Biopharma and Cytovance announced a collaboration agreement whereby Cytovance will providing drug development…
-
Biotechnology | COVID-19 | Disease | Medicine | NIH | Therapeutics
La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19
On Aug. 20, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes…
-
Evidence suggested children could play a larger role in community spread of COVID-19
On Aug. 20, 2020, in the most comprehensive study of COVID-19 pediatric patients to date, Harvard Medical School…
-
OpGen announced CE-IVD Mark and commercial launch in EU of molecular diagnostic with PULB for detection of COVID-19
On Aug. 20, 2020, OpGen announced that its subsidiary Curetis GmbH had obtained the CE mark certification in…
-
Pfizer and BioNTech shared positive early data on lead mRNA vaccine candidate BNT162b2 against COVID-19
On Aug. 20, 2020, Pfizer and BioNTech shared additional Phase 1 safety and immunogenicity data from their U.S….
-
BioNexus KC awarded grant to improve COVID-19 outcomes for patients with underlying health conditions
On Aug. 19, 2018, BioNexus KC announced it had been awarded a $42,900 grant from the Health Forward…
-
Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabs
On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofiaﾮ SARS…
-
Accelerate Diagnostics announced FDA Emergency Use Authorization for COVID-19 antibody testing system
On Aug. 19, 2020, Accelerate Diagnostics and BioCheck announced that the FDA had issued an Emergency Use Authorization…
-
NIH imposed ‘outrageous’ conditions on resuming coronavirus grants
On Aug. 19, 2020, the National Institutes of Health (NIH) began requiring a small nonprofit research organization to…
